Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
kSvL3LAQ73Pr3jwU